Trends in Molecular Medicine

Fly-ing from genes to drugs
pp. 99-101(3)
Author: Chan H.Y.E.

Functions of the fragile X protein
pp. 102-103(2)
Author: Oostra B.A.

Hijacking of key signaling pathways by H. pylori
pp. 106-106(1)
Author: Ward S.

Fusion protein delays Wallerian degeneration
pp. 106-107(2)
Author: Hafezparast M.

In Brief
pp. 107-108(2)
Authors: Weitzman J.; O'Neill P.

Microchimerism: incidental byproduct of pregnancy or active participant in human health?
pp. 109-113(5)
Author: Nelson J.L.

Medicinal chemistry and therapeutic potential of CpG DNA
pp. 114-121(8)
Authors: Agrawal S.; Kandimalla E.R.

New immunotherapeutic strategies to control vaginal candidiasis
pp. 121-126(6)
Authors: Magliani W.; Conti S.; Cassone A.; De Bernardis F.; Polonelli L.

Glycogen synthase kinase 3: an emerging therapeutic target
pp. 126-132(7)
Author: Eldar-Finkelman H.

Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans
pp. 133-139(7)
Authors: van Bokhoven H.; McKeon F.

Disease model: Fanconi anemia
pp. 139-142(4)
Authors: Wong J.C.Y.; Buchwald M.

Embryo and stem cell research in the USA: a political history
pp. 143-146(4)
Author: Wertz D.C.

Salvation through science
pp. 146-147(2)
Author: Ashcroft R.

Prions updated
pp. 147-147(1)
Author: Ironside J.W.